Proactive Investors - Run By Investors For Investors

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.
 
Hall says there has been a shortfall in the standard of quality healthcare today and Medlab is looking to provide better new health solutions.
 
The company is doing extensive work exploring the role gut health plays in chronic illnesses and developing quality nutraceuticals, popular treatments that contributed towards Medlab's revenue milestones last month.
Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
Meet Cardinal Resources Ltd, Legend Mining Ltd and Danakali Ltd at our event, Melbourne , 16 July 2019. Register here »
View full MDC profile View Profile

Medlab Clinical Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use